DONNA SCHULTICE: Open Payments
NPI 1710403969 · CAMDEN, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$633 in 42 payments from 12 companies in 2025. Trend: 2023 $497 · 2024 $331 · 2025 $633
Food & beverage: $633
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 15 | $203 |
| ABBVIE INC. | 11 | $171 |
| Exact Sciences Corporation | 2 | $34 |
| PFIZER INC. | 2 | $33 |
| Lilly USA, LLC | 2 | $33 |
| Abbott Laboratories | 2 | $31 |
| Dexcom, Inc. | 2 | $30 |
| Kowa Pharmaceuticals America, Inc. | 2 | $30 |
| Novartis Pharmaceuticals Corporation | 1 | $20 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $17 |
Products named: QULIPTA, UBRELVY, Ozempic, Rybelsus, The Cologuard Plus Collection Kit, FREESTYLE LIBRE 3, Dexcom G6 Transmitter, ZORYVE.
Industry payments across NJ — which companies pay providers there.
